<DOC>
	<DOC>NCT01842633</DOC>
	<brief_summary>The purpose of this multi-center study is to assess the efficacy of headache relief of new paracetamol/caffeine formulation compared to placebo and ibuprofen in episodic tension-type headache (ETTH).</brief_summary>
	<brief_title>Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Participants in good general health, and with diagnosis of ETTH with following conditions: 1. number of days with the condition is historically greater than or equal to two per month; 2. severity of headaches is historically at least moderate; 3. duration of headaches is historically more than or equal to 4 hours, if untreated. Participant with known or suspected hypersensitivity, allergy, intolerance or contraindication to the use of any of the study medications Participant has chronic tension type headache, psychiatric disease or a significant cognitive disorder, or any chronic pain disorder. Participant currently taking or has taken medications or herbal supplements within the three months that are likely to interfere with the validity of subjectrated assessments.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>